Skip to main content
OpenTrials
Completed

NCT Number: NCT05615181

Evaluation of the French Translation of Gothenburg Trismus Questionnaire (GTQ)

A monocentric Study to evaluate the french translation of Gothenburg Trismus Questionnaire (GTQ).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trismus Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Spasm

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ch Valence

Valence, Drome, 26953, France

About this study

Trismus is defined as a limitation in the mouth/jaw-opening ability due to a reduced mandible mobility. Trismus can occur from benign jaw related conditions, often referred to as temporomandibular disorders (TMD). It can also result from local or metastatic tumor growth of head and neck (H&N) tumors, and more importantly, as a debilitating side-effect to H&N oncology treatment, especially radiotherapy

The Gothenburg Trismus Questionnaire (GTQ) is a Patient Reported Outcome, validated in English, portuguese and sweden language.

The aim of this study is to develop a new tool in french language and to evaluate the specific impact of trismus on quality of life .

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:
  • Patient treated for trismus
  • Age ≥ 18 years old
  • Read, write and understand the French language
  • Exclusion Criteria:
  • Patient under guardianship, deprived of liberty, safeguard of justice
  • Refusal to participate in research

Treatment and study plan

Primary outcomes

  1. Gothenburg Trismus Questionnaire (GTQ)

    Time frame: once at inclusion

    patient Reported Outcome measure: score 0-4 (0 means a better outcome, 4 means a worse outcome.)

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Valence

Other

Collaborators

  • Göteborg University

Registry information

Acronym: TRISMUS

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Nov 14, 2022
Registry last updated
Sep 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.